Integrin-mediated Axoglial Interactions Initiate Myelination in the Central Nervous System
Overview
Authors
Affiliations
All but the smallest-diameter axons in the central nervous system are myelinated, but the signals that initiate myelination are unknown. Our prior work has shown that integrin signaling forms part of the cell-cell interactions that ensure only those oligodendrocytes contacting axons survive. Here, therefore, we have asked whether integrins regulate the interactions that lead to myelination. Using homologous recombination to insert a single-copy transgene into the hypoxanthine phosphoribosyl transferase (hprt) locus, we find that mice expressing a dominant-negative beta1 integrin in myelinating oligodendrocytes require a larger axon diameter to initiate timely myelination. Mice with a conditional deletion of focal adhesion kinase (a signaling molecule activated by integrins) exhibit a similar phenotype. Conversely, transgenic mice expressing dominant-negative beta3 integrin in oligodendrocytes display no myelination abnormalities. We conclude that beta1 integrin plays a key role in the axoglial interactions that sense axon size and initiate myelination, such that loss of integrin signaling leads to a delay in myelination of small-diameter axons.
Osso L, Hughes E Nat Neurosci. 2024; 27(8):1449-1461.
PMID: 38773349 PMC: 11515933. DOI: 10.1038/s41593-024-01642-2.
Seiler S, Walti C, de Barros V, Barbash S, Foo L Sci Rep. 2023; 13(1):2883.
PMID: 36805690 PMC: 9938858. DOI: 10.1038/s41598-023-29333-1.
Chronic oligodendrocyte injury in central nervous system pathologies.
Molina-Gonzalez I, Miron V, Antel J Commun Biol. 2022; 5(1):1274.
PMID: 36402839 PMC: 9675815. DOI: 10.1038/s42003-022-04248-1.
The molecular regulation of oligodendrocyte development and CNS myelination by ECM proteins.
Yamada M, Iwase M, Sasaki B, Suzuki N Front Cell Dev Biol. 2022; 10:952135.
PMID: 36147746 PMC: 9488109. DOI: 10.3389/fcell.2022.952135.
de Almeida V, Seabra G, Reis-de-Oliveira G, Zuccoli G, Rumin P, Fioramonte M Eur Arch Psychiatry Clin Neurosci. 2022; 272(7):1311-1323.
PMID: 35622101 DOI: 10.1007/s00406-022-01425-5.